| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 681645 | Camptothecin Derivative | 0.00404192617431249 | 0.61898815 |
| NSC 684440 | Null | 0.00404192617431249 | 0.45573268 |
| NSC 688021 | Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (5-nitro-2-thienyl)methyl ester | 0.00404192617431249 | 0.50314037 |
| NSC 704533 | Null | 0.00404192617431249 | 0.50735226 |
| NSC 712001 | Null | 0.00404192617431249 | 0.1796944 |
| NSC 716258 | Null | 0.00404192617431249 | 0.20608297 |
| NSC 725774 | 6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride | 0.00404192617431249 | 0.5545644 |
| NSC 727354 | 6-[(4-FMOCamino)-1-butyl]-5,6-dihydro-2,3-dimethoxy-8,9-meth ylenedioxy-5,11-dioxo-11H-indeno[1,2-c-isoquinoline | 0.00404192617431249 | 0.47867667 |
| NSC 735037 | Camptothecin Derivative | 0.00404192617431249 | 0.55225468 |
| NSC 740520 | 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.00404192617431249 | 0.74423871 |